Global Bioresorbable Scaffolds Market

Bioresorbable Scaffolds Market Size, Share, Growth Analysis, By Type(Drug Eluting Coronary Scaffolds, Sirolimus-Eluting Device, Everolimus-Eluting Device, Novolimus-Eluting Device), By Material(Absorbable Magnesium Stent (AMS), Polymeric Scaffold, Polycarbonate Scaffold, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2472 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 66 | Figures: 70

Bioresorbable Scaffolds Market Insights

Global Bioresorbable Scaffolds Market size was valued at USD 374.94 million in 2022 and is poised to grow from USD 416.56 million in 2023 to USD 966.92 million by 2031, growing at a CAGR of 11.10% during the forecast period (2024-2031).

The bioresorbable scaffolds market is witnessing significant growth owing to advancements in medical technology and the increasing prevalence of cardiovascular diseases. Bioresorbable scaffolds are temporary implants used to treat coronary artery diseases, gradually dissolving over time while allowing the vessel to heal naturally. This market is segmented into material type, application, end-user, and region.

The market's material type segment includes polymer-based and metal-based scaffolds. Polymer-based scaffolds dominate the market due to their biocompatibility and gradual resorption properties. Cardiovascular diseases, orthopedic disorders, and others comprise the application segment, with cardiovascular diseases leading the demand due to a high incidence rate.

Hospitals, ambulatory surgical centers, and specialized clinics constitute the end-user segment. The rising number of hospital admissions for cardiac interventions drives the demand for bioresorbable scaffolds. Geographically, North America commands a significant market share due to well-established healthcare infrastructure and increasing cardiovascular disease cases. Europe follows with a strong focus on research and development, while the Asia-Pacific region is witnessing growth due to the rise in healthcare investments and the aging population.

Factors driving the market include the growing elderly population, demand for minimally invasive procedures, and technological advancements. However, challenges like high costs and the need for skilled professionals hinder market growth. With ongoing research to enhance scaffold properties and efficacy, the bioresorbable scaffolds market is anticipated to expand in the coming years.

US Bioresorbable Scaffolds Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Bioresorbable Scaffolds Market size was valued at USD 374.94 million in 2022 and is poised to grow from USD 416.56 million in 2023 to USD 966.92 million by 2031, growing at a CAGR of 11.10% during the forecast period (2024-2031).

The competitive landscape of the bioresorbable scaffolds market encompasses comprehensive insights into each competitor. These insights encompass various aspects, including an overview of the company, its financial standing, revenue generation, market potential, research and development investments, novel market strategies, reach, production facilities, capacities, strengths, weaknesses, product launches, breadth of offerings, and dominant applications. Notably, the information provided pertains solely to the strategic direction of these companies in the context of the bioresorbable scaffolds market. 'Abbott', 'Medtronic', 'Boston Scientific Corporation', 'Biotronik', 'Elixir Medical Corporation', 'REVA Medical', 'Amaranth Medical', 'Kyoto Medical Planning', 'Xenogenics Corporation', 'B. Braun', 'Cardinal Health', 'Lombard Medical', 'Translumina', 'MicroPort Scientific Corporation', 'TERUMO CORPORATION'

The escalating prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is a major driver for the bioresorbable scaffolds market. These conditions necessitate advanced treatments to restore blood flow, creating a demand for innovative solutions like bioresorbable scaffolds.

Increasing elderly population requires frequent healthcare services, driving the demand for bioresorbable scaffolds as older individuals are more susceptible to cardiovascular diseases.

The dominance of the bioresorbable scaffolds market stands with North America, attributed to several factors such as a significant population affected with cardiovascular diseases, a multitude of prominent companies operating in the region, and an increasing elderly demographic. Moreover, the rise in obesity and diabetes cases, sedentary lifestyles, heightened stress levels, and desk-bound routines have collectively propelled market growth. Following the Americas, Europe holds the second-largest market share, trailed by the Asia Pacific region. Notably, Asia Pacific stands out as the rapidly growing market due to its swift technological advancements and a substantial patient pool grappling with various vascular disorders. On the other hand, the Middle East & Africa region accounts for the least share in the bioresorbable scaffolds market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Bioresorbable Scaffolds Market

Report ID: SQMIG35A2472

$5,300
BUY NOW GET FREE SAMPLE